EASL | The Home of Hepatology’s Post

Boehringer Ingelheim and EVICR.net announce a new partnership to support the development of the EVICR.net Eye Platform. The Eye Platform is a long-term initiative to collect longitudinal anonymised clinical data and eye images from the network’s centers across Europe. The data platform will be available for analysis by all EVICR.net partners to develop a better understanding of the progression of eye diseases and new ways to improve patient care and prevent vision loss.   Boehringer Ingelheim is funding the EVICR.net Eye Platform and a pilot study that is collecting and will analyze data in patients with intermediate AMD or early atrophic AMD under the scientific coordination of Prof. Sobha Sivaprasad from EVICR.net CS nº 10 – Moorfields Eye Hospital, London, UK.   Want to get involved? Learn more at https://lnkd.in/dtfN_Mfx #evicrnet #boehringeringlheim #clinicalresearch #ophthalmology #clinicaldata #eyediseases #dataanalysis

For more information on this Oral Abstract where GOG-3059 will be presented during the 2024 ASCO Annual Meeting, go to https://ow.ly/4QV050S0FhW or click in bio. #clinicaltrials #GOGF #GOGPartners #GynecologicOncology #ASCO24

🌟 Take a glimpse into the groundbreaking work happening at IPATH, a hub of innovation and excellence within the field of medicine. 💊🔬 Our team is dedicated to pioneering research, driving advancements, and pushing the boundaries of what's possible in the fight against #antimicrobialresistance. 🦠💪 Curious to learn more about our cutting-edge projects, collaborations, and the transformative impact of phage therapies? 💡 Dive into the details on our website. 🚀 Here's why you should explore it!: 1️⃣ In-Depth Insights: Uncover the science behind phage applications and therapeutics with detailed information on our ongoing research initiatives. 2️⃣ Meet the Experts: Get to know the brilliant minds behind the groundbreaking discoveries, their expertise, and the passion driving our mission. 3️⃣ Impactful Stories: Discover real-life stories showcasing the positive impact of phage therapies on patients' lives. Join us on this journey of discovery, innovation, and healing! 🌍💙 Your support and interest make a difference. Feel free to like, share, and spread the word! Together, let's make strides in transforming healthcare and shaping a healthier future. #PhageTherapeutics #InnovationInMedicine #HealthcareRevolution #ResearchExcellence

For sure if you don't know a clinical trial is even going on there is zero possibility of participating 🧐 Check out Lupus Research Alliance for #clinicaltrials near you 💜💜 Would you participate in a #clinicaltrial if asked? Comment below ⏩ Episode 3 Living Room | Clinical Trials • Where is the Diversity feat. Ashira Blazer #thelupiefam #lupiefam #lupusawareness

World Duchenne Awareness Day commemorative webinar on the power of gut microbiome in DMD; A report on pre-clinical evidence and outcome of two clinical studies in DMD & one in LGMD; 10 Sep, 2023: https://lnkd.in/gY-3gEPR #musculardystrophy

Today, kicks off our 4th annual Lupus Clinical Investigators Network (LuCIN) Community Meeting, hosted by #LupusTherapeutics, the clinical affiliate of the Lupus Research Alliance. This annual meeting brings people with #lupus together with thought leaders, clinical investigators, study coordinators, research & industry partners to discuss the progress and advancements being made in #LupusClinicalResearch and treatment, and the importance of health equity and access in #lupus clinical trials. Learn more about LuCIN at https://bit.ly/LuCIN2024 #LuCINCommunity #LupusAwarenessMonth

For more information on this Oral Abstract where GOG-3055 will be presented during the 2024 ASCO Annual Meeting, go to https://ow.ly/EjtA50S0F6u or click in bio. #clinicaltrials #GOGF #GOGPartners #GynecologicOncology #ASCO24

For more information on this Oral Abstract where GOG-0724 will be presented during the 2024 ASCO Annual Meeting, go to https://ow.ly/3NML50RUlVV or click in bio. #clinicaltrials #GOGF #GOGPartners #GynecologicOncology #ASCO24

So often, rare patients don't have or can't access the basic resources and information they need to understand their condition. We are honored to be working with Dr. John Stone MD, MPH to help provide desperately needed resources, like the upcoming IgG4ward! Fireside Chat, for IgG4-RD patients, caregivers, and healthcare professionals. #rarediseaseawareness #autoimmunediseases #rarediseaseadvocacy

If you are interested in psychedelic clinical research and want to know more about some of the challenges these studies present - and how we at MAC overcome them - do take a listen to this talk by our expert Dr. Shoona Alousious Vincent. Some great insights.